BioTelemetry, Inc. Names Dr. Andrei Stoica Chief Technology Officer

MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Dr. Andrei Stoica has been named Chief Technology Officer of the company.  Dr. Stoica will lead the company’s […]

April 7, 2020

BIOTELEMETRY, INC. EXPANDS MCOT™ SERVICE TO MONITOR LIFE-THREATENING QT PROLONGATION IN COVID-19 PATIENTS

Only remote cardiac monitoring company whose proprietary connected system has FDA-approved indication to measure, analyze and report QT interval MALVERN, Pa., March 25, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced […]

March 25, 2020

A COVID-19 Message from Joe Capper, President & CEO—Our Commitment to You

  Dear BioTelemetry Community, The health and safety of you and your patients is our highest priority.  As we work together during this challenging time, I want to assure you that we have never been more focused on making sure that you have the support you need from our company.   It is our privilege to […]

March 23, 2020

BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results

Announces Record Quarterly and Full Year Results MALVERN, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter and year ended December 31, 2019. Quarter Highlights Recognized […]

February 26, 2020

BioTelemetry, Inc. to Release Fourth Quarter 2019 Earnings Results on February 26, 2020

MALVERN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2019 earnings on Wednesday, February 26 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 26, 2020. The broadcast will be available through the investor information section of […]

February 18, 2020

The Apple Heart Study findings have been published in NEJM.

In the study, participants who received an irregular rhythm notification on the Apple Watch wore the BioTelemetry ECG patch recorder, ePatch™, for up to 7 days to confirm atrial fibrillation.

November 20, 2019